Michael T. Andriole's Net Worth
$3.86 Million
Who is Michael T. Andriole?
Michael T. Andriole has an estimated net worth of $3.86 Million. This is based on reported shares across multiple companies, which include CHIMERIX INC, and ENDOCYTE INC.
SEC CIK
Michael T. Andriole's CIK is 0001698751
Past Insider Trading and Trends
2023 was Michael T. Andriole's most active year for acquiring shares with 5 total transactions. Michael T. Andriole's most active month to acquire stocks was the month of January. 2018 was Michael T. Andriole's most active year for disposing of shares, totalling 10 transactions. Michael T. Andriole's most active month to dispose stocks was the month of November. 2019 saw Michael T. Andriole paying a total of $156,000.00 for 600,000 shares, this is the most they've acquired in one year. In 2018 Michael T. Andriole cashed out on 325,000 shares for a total of $6,623,816.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CHIMERIX INC (CMRX) Snapshot price: $0.8503
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.28% | -1.28K |
$0.83 | -$1,064.62 | 462.45K |
Aug 8
| |||
Form 4
| -0.39% | -1.74K |
$1.04 | -$1,809.40 | 447.02K |
Feb 14
| |||
Form 4
| +22.94% | 83.75K |
—
|
—
| 448.76K |
Feb 1
| |||
Form 4
| -4.45% | -17.00K |
—
|
—
| 365.01K |
Dec 29
| |||
Form 4
| +7.00% | 25K |
$1.19 | $29,750.00 | 382.01K |
Aug 1
| |||
Form 4
| +16.93% | 51.7K |
$1.14 | $59,149.97 | 357.01K |
May 18
| |||
Form 4
| +12.25% | 32.17K |
—
|
—
| 294.9K |
Jan 17
| |||
Form 4
| +23.50% | 50K |
$2.09 | $104,500.00 | 262.72K |
Aug 25
| |||
Form 4
| +7.59% | 15K |
$1.71 | $25,635.00 | 212.72K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +28.60% | 33.3K |
$1.43 | $47,522.43 | 149.73K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
∞
| 100K |
$1.56 | $156,000.00 | 100K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOCYTE INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -152.58K |
$24.00 | -$3,661,968.00 |
0
|
Dec 21
| |||
Form 4
| +15.52% | 20.5K |
$2.22 | $55,500.00 | 152.58K |
Dec 17
| |||
Form 4
| -11.95% | -17.92K |
$15.56 | -$278,848.24 | 132.08K |
Scheduled
|
Oct 5 - Oct 9
| ||
Form 4
| +20.00% | 25K |
—
|
—
| 150K |
Feb 8
| |||
Form 4
| +150.00% | 75K |
—
|
—
| 125K |
Oct 4
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||